Xtant Medical Holdings (XTNT) EPS (Basic) Growth (3y) (2013 - 2025)
Xtant Medical Holdings (XTNT) EPS (Basic) Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.19 Bn | 194.59 Bn | 7.27 Bn | -12.28% |
| 2 | Stryker | 129.95 Bn | 126.47 Bn | 4.50 Bn | 19.63% |
| 3 | Medtronic | 120.06 Bn | 110.84 Bn | 6.41 Bn | 3.18% |
| 4 | Boston Scientific | 74.14 Bn | 73.60 Bn | 3.85 Bn | 50.64% |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn | -6.23% |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn | 29.56% |
| 7 | GE HealthCare Technologies | 34.20 Bn | 32.10 Bn | 2.18 Bn | 11.31% |
| 8 | Koninklijke Philips | 26.46 Bn | 23.13 Bn | 4.55 Bn | 1,801.39% |
| 9 | Steris | 23.25 Bn | 22.77 Bn | 684.20 Mn | 17.98% |
| 10 | Xtant Medical Holdings | 47.41 Mn | 29.81 Mn | 17.75 Mn | 28.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 26.36% |
| Sep 30, 2025 | 33.35% |
| Jun 30, 2025 | 48.90% |
| Mar 31, 2025 | 26.34% |
| Dec 31, 2024 | -16.95% |
| Sep 30, 2024 | -21.38% |
| Jun 30, 2024 | -51.92% |
| Mar 31, 2024 | -355.78% |
| Dec 31, 2023 | -28.12% |
| Sep 30, 2023 | 39.26% |
| Jun 30, 2023 | 52.39% |
| Mar 31, 2023 | 53.45% |
| Dec 31, 2022 | -52.59% |
| Sep 30, 2022 | 43.89% |
| Jun 30, 2022 | 48.96% |
| Mar 31, 2022 | 50.75% |
| Dec 31, 2021 | 85.47% |
| Sep 30, 2021 | 55.73% |
| Jun 30, 2021 | 71.93% |
| Mar 31, 2021 | 92.02% |